Countries using and planning
to introduce IPV
1|
Countries using and planning to introduce IPV
May 2015 status report
This slide deck provides a summary per country on the status of planning for the
introduction of Inactivated Poliomyelitis Vaccine (IPV).
Information here is updated monthly based on information shared by WHO and UNICEF Regional
Offices. Please contact [email protected] with any questions or updates on this data.
Definitions
 Formal decision to introduce: The country has documentation of its decision to introduce
IPV which has been verified by the relevant WHO Regional Office, or for GAVI eligible
countries, a complete application for IPV has been submitted to the GAVI Secretariat.
 Intent to introduce: The country has informally indicated that it plans to introduce IPV, e.g.
planning an application to GAVI, or by requesting technical assistance to develop an IPV
introduction plan.
Tracking these decisions and informal intents provide an indication of the global trend towards
meeting the targets of the Polio Eradication and Endgame Strategic Plan.
2|
Countries using IPV vaccine to date
and formal decision/intent to introduce
Introduced to date
(87 countries or 45%)
Formal commitment to introduce in 2015 (103 countries or 53%)
Intend to introduce in 2015
(4 countries or 2%)
(Cook Islands, Fiji, Mauritius, Thailand)
Since January 2013, the following countries have introduced IPV: Kazakhstan
& Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July
2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China
(December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & ;
Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea,
DR Congo and Gambia (April 2015)
Data source: WHO/IVB Database, as of 01 May 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Not applicable
3|
Date of slide: 1 May 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.
Countries using IPV vaccine to date and introductions
planned according to Gavi eligibility status
Introduced to date
Since January 2013, the following countries have introduced IPV: Kazakhstan
& Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July
2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China
(December 2014); Comoros, Senegal & Serbia (January 2015); Colombia &
Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea,
DR Congo and Gambia (April 2015)
(87 countries or 45%)
Gavi countries with formal commitment
(64 countries or 33%)
to introduce in 2015
Non Gavi countries with formal
(39 countries or 20%)
commitment to introduce in 2015
Non Gavi countries with intent to introduce in 2015
(Cook Islands, Fiji, Mauritius, Thailand)
(4 countries or 2%)
Not applicable
4|
Date of slide: 1 May 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.
Data source: WHO/IVB Database, as of 01 May 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
107 countries introducing IPV between May
2015 and December 2015
May
June
July
August
September
October
November
December
Madagascar
Sudan
Botswana
Cameroon
Chad
Cote d'Ivoire
Grenada
Guyana
Haiti
Kiribati
Lesotho
Mali
Morocco
Nauru
Niger
St Vincent & the Grenadines
Tuvalu
Azerbaijan
Bahamas
Bhutan
Cabo Verde
Chile
Iraq
Kenya
Malawi
Mauritania
Myanmar
Pakistan
Sri Lanka
Argentina
Cuba
Namibia
Papua New Guinea
Macedonia
Afghanistan
Benin
CAR
Djibouti
Dominican Republic
Gabon
Ghana
Iran
Jamaica
Mozambique
Seychelles
Solomon Islands
South Sudan
Swaziland
Timor-Leste
Trinidad & Tobago
Vanuatu
Angola
Antigua & Barbuda
Armenia
Belize
Bolivia
Burkina Faso
Cambodia
Congo (the)
Cook Islands
Egypt
Equatorial Guinea
Ethiopia
Fiji
Guinea-Bissau
Honduras
India
Lao PDR
Liberia
Mongolia
Nicaragua
Rep. of Moldova
Rwanda
Saint Kitts & Nevis
Samoa
Sao Tome & Principe
Sierra Leone
Somalia
Tajikistan
Togo
Tonga
Uganda
Tanzania
Uzbekistan
Viet Nam
Zimbabwe
Algeria
Barbados
Burundi
Dominica
Eritrea
Indonesia
Suriname
Thailand
Turkmenistan
Zambia
Ecuador
El Salvador
Georgia
Guatemala
Guinea
Kyrgyzstan
Paraguay
St Lucia
Venezuela
n= 35
n= 10
n= 2
n= 15
n= 12
n= 5
n= 17
Legend
Tier 1 countries
5|
Tier 2 countries
Intent to introduce
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic
countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3
coverage <80% in the past 3 years as per WUENIC
Yemen and Mauritius
are introducing in 2015
but no month of
introduction available.
n= 9
Source: WHO/UNICEF
database as at 01 May 2015
64/73 Gavi countries introducing IPV
between May 2015 and December 2015
May
June
July
August
September
October
November
December
Madagascar
Sudan
Cameroon
Chad
Cote d'Ivoire
Guyana
Haiti
Kiribati
Lesotho
Mali
Niger
Azerbaijan
Bhutan
Kenya
Malawi
Mauritania
Myanmar
Pakistan
Sri Lanka
Cuba
Papua New Guinea
Afghanistan
Benin
CAR
Djibouti
Ghana
Mozambique
Solomon Islands
South Sudan
Timor-Leste
Angola
Armenia
Bolivia
Burkina Faso
Cambodia
Congo (the)
Ethiopia
Guinea-Bissau
Honduras
India
Lao PDR
Liberia
Mongolia
Nicaragua
Rep. of Moldova
Rwanda
Sao Tome & Principe
Sierra Leone
Somalia
Tajikistan
Togo
Uganda
Tanzania
Uzbekistan
Viet Nam
Zimbabwe
Burundi
Eritrea
Indonesia
Suriname
Zambia
Georgia
Guinea
Kyrgyzstan
n= 26
n= 5
n= 2
n= 9
n= 8
n= 2
n= 9
Yemen is introducing in
2015 but no month of
introduction available.
n= 3
Legend
Tier 1 countries
6|
Tier 2 countries
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic
countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3
coverage <80% in the past 3 years as per WUENIC
Source: WHO/UNICEF
database as at 01 May 2015
Tier 1 and 2 Countries using IPV vaccine to date
and formal decision to introduce
Introduction to date
(4 countries or 11%)
Formal commitment to introduce in 2015
(31 countries or 89%)
Since January 2013, the following Tier 1 and 2 countries have introduced IPV:
The Philippines (October 2014), China (December 2014), Nigeria (February
2015) and DR Congo (April 2015)
Not Applicable or not Tier 1 or 2 countries
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries
with DTP3 coverage <80% in the past 3 years as per WUENIC
7|
Date of slide: 1 May 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.
Data source: WHO/IVB Database, as of 01 May 2015,
based on 35 tier 1 & 2 countries
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Middle Income Countries using IPV vaccine to date
and formal/intent decision to introduce
Introduced to date (32 countries or 32%)
Since January 2013, the following MIC have introduced IPV:
Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May
2014); Panama (July 2014); Tunisia (September 2014); Philippines (October
2014); China (December 2014); Senegal (January 2015); Serbia (January 2015);
Colombia (February 2015) and Maldives (March 2015)
Formal commitment to introduce in 2015 (65 countries or 65%)
Intend to introduce in 2015
(Fiji, Mauritius, Thailand)
(3 countries or 3%)
Data source: WHO/IVB Database, as of 01 May 2015 based on 100
middle income countries (MIC) as per last World Bank classification
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Not applicable / Not MIC countries
8|
Date of slide: 1 May 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.
IPV introduction status and planned introduction
by quarter by the end of 2015
Introduced to date
(87 countries or 45%)
Introduction planned in Q2 2015
(17 countries or 9%)
Introduction planned in Q3 2015
(34 countries or 18%)
Introduction planned in Q4 2015
(54 countries or 27%)
Since January 2013, the following countries have introduced IPV: Kazakhstan
& Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July
2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China
(December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & ;
Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea,
DR Congo and Gambia (April 2015)
Introduction planned in 2015 but month of (2 countries or 1%)
introduction not known (Mauritius, Yemen)
Data source: WHO/IVB Database, as of 01 May 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Not applicable
9|
Date of slide: 1 May 2015
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
©WHO 2015. All rights reserved.